Risk factors for treatment failure in orthopedic device-related methicillin-resistant Staphylococcus aureus infection.

Szczegóły
Abstrakt

Tytuł:: Risk factors for treatment failure in orthopedic device-related methicillin-resistant Staphylococcus aureus infection.
Autorzy:: Ferry T; Infectious Diseases Unit, Geneva University Hospitals and Faculty of Medicine, Geneva, Switzerland. />Uçkay I
Vaudaux P
François P
Schrenzel J
Harbarth S
Laurent F
Bernard L
Vandenesch F
Etienne J
Hoffmeyer P
Lew D
Źródło:: European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology [Eur J Clin Microbiol Infect Dis] 2010 Feb; Vol. 29 (2), pp. 171-80. Date of Electronic Publication: 2009 Nov 28.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
Język:: English
Imprint Name(s):: Publication: Berlin : Springer
Original Publication: [Wiesbaden, Federal Republic of Germany] : Vieweg, [c1988-
MeSH Terms:: Anti-Bacterial Agents/*therapeutic use
Methicillin-Resistant Staphylococcus aureus/*isolation & purification
Prosthesis-Related Infections/*drug therapy
Staphylococcal Infections/*drug therapy
Aged ; Aged, 80 and over ; Anti-Bacterial Agents/pharmacology ; Bacterial Typing Techniques ; Cohort Studies ; Female ; Genotype ; Humans ; Male ; Microbial Sensitivity Tests ; Middle Aged ; Orthopedic Procedures/adverse effects ; Retrospective Studies ; Risk Factors ; Staphylococcal Infections/microbiology ; Switzerland ; Treatment Failure ; Vancomycin/pharmacology ; Vancomycin/therapeutic use
References:: JAMA. 1998 May 20;279(19):1537-41. (PMID: 9605897)
J Clin Microbiol. 2008 Oct;46(10):3454-8. (PMID: 18667599)
N Engl J Med. 2004 Oct 14;351(16):1645-54. (PMID: 15483283)
Antimicrob Agents Chemother. 1990 Oct;34(10):1869-74. (PMID: 2149812)
Emerg Infect Dis. 2008 Feb;14(2):304-7. (PMID: 18258126)
Antimicrob Agents Chemother. 2000 May;44(5):1247-54. (PMID: 10770759)
Infect Immun. 2002 Feb;70(2):631-41. (PMID: 11796592)
J Clin Microbiol. 2005 Jul;43(7):3346-55. (PMID: 16000459)
J Infect Dis. 2005 Sep 1;192(5):801-10. (PMID: 16088829)
J Infect Dis. 1990 Jul;162(1):96-102. (PMID: 2355207)
J Clin Microbiol. 2006 Jul;44(7):2642-4. (PMID: 16825403)
Clin Infect Dis. 2003 May 1;36(9):1157-61. (PMID: 12715311)
Antimicrob Agents Chemother. 2007 Jan;51(1):264-74. (PMID: 17043114)
Clin Infect Dis. 1997 May;24(5):914-9. (PMID: 9142792)
Clin Infect Dis. 1998 Nov;27(5):1247-54. (PMID: 9827278)
Science. 1987 Sep 25;237(4822):1588-95. (PMID: 3629258)
J Hosp Infect. 2006 May;63(1):93-100. (PMID: 16542756)
Clin Infect Dis. 2008 Apr 15;46(8):1221-6. (PMID: 18444859)
Antimicrob Agents Chemother. 2007 Jul;51(7):2582-6. (PMID: 17452488)
Lancet. 2004 Jul 24-30;364(9431):369-79. (PMID: 15276398)
Clin Infect Dis. 2001 Sep 1;33 Suppl 2:S94-106. (PMID: 11486305)
Clin Orthop Relat Res. 2002 Nov;(404):116-24. (PMID: 12439249)
J Chronic Dis. 1987;40(5):373-83. (PMID: 3558716)
Clin Infect Dis. 2006 Feb 15;42(4):471-8. (PMID: 16421790)
Clin Infect Dis. 2008 Jan 15;46(2):193-200. (PMID: 18171250)
Ann Intern Med. 1993 Feb 1;118(3):201-10. (PMID: 8417638)
Orthopedics. 1991 Aug;14(8):841-4. (PMID: 1923965)
Clin Orthop Relat Res. 2007 Aug;461:48-53. (PMID: 17534195)
Infection. 2003 Mar;31(2):99-108. (PMID: 12682815)
Nat Rev Microbiol. 2006 Apr;4(4):295-305. (PMID: 16541137)
J Bone Joint Surg Am. 1990 Jul;72(6):878-83. (PMID: 2365721)
Lancet Infect Dis. 2002 Mar;2(3):180-9. (PMID: 11944188)
J Antimicrob Chemother. 1997 Feb;39(2):235-40. (PMID: 9069545)
Substance Nomenclature:: 0 (Anti-Bacterial Agents)
6Q205EH1VU (Vancomycin)
Entry Date(s):: Date Created: 20091201 Date Completed: 20100317 Latest Revision: 20211020
Update Code:: 20240104
DOI:: 10.1007/s10096-009-0837-y
PMID:: 19946789
: Czasopismo naukowe

Full Text Finder

The purpose of this study was to determine the clinical and microbiological risk factors for treatment failure of methicillin-resistant Staphylococcus aureus (MRSA) orthopedic device-related infection (ODRI). A retrospective cohort study of patients with MRSA ODRI who were treated at Geneva University Hospitals between 2000 and 2008 was undertaken. Stored MRSA isolates were retrieved for genetic characterization and determination of the vancomycin minimum inhibitory concentration (MIC). Fifty-two patients were included, of whom 23 (44%) had joint arthroplasty and 29 (56%) had osteosynthesis. All 41 of the retrieved MRSA isolates were susceptible to vancomycin (MIC

Informacja